logo-loader
RNS
Target Healthcare REIT

Target H'care REIT - Disposal of four care homes for £44.5 million

RNS Number : 0474U
Target Healthcare REIT PLC
27 June 2024
 

27 June 2024

Target Healthcare REIT plc and its subsidiaries

("Target Healthcare" or "the Group")

Disposal of four care homes for £44.5 million

Target Healthcare (LSE: THRL) announces that it has completed the disposal of four UK care homes for £44.5 million to the incumbent tenant. The sale price reflects a modest premium to the portfolio's carrying value at both 31 December 2023 (the latest date prior to the offer being received) and 31 March 2024, and an implied net initial yield of 5.64%.

Proceeds from the disposal, which represented 326 beds and c.4.6% of the Group's overall portfolio value, will enable a partial repayment of the Group's revolving credit facilities and therefore reduce its unhedged interest cost. Overall, the disposal reduces net LTV by approximately 3.8%.

These assets were originally constructed in 2007/08, and were consequently amongst the oldest assets in the Group's portfolio, and had a c.12% lower gross internal floor space per resident than the portfolio's weighted average. In addition, these assets represented the Group's four shortest lease terms, with an average of 13.6 years remaining. Following the disposal, the portfolio's weighted average unexpired lease term increases to 26.3 years from 25.8 years, and the Group's weighting to Yorkshire and the Humber reduces, an area that was previously its largest geographical exposure.

These properties were originally acquired as part of the significant portfolio acquisition in December 2021. Despite the relatively short holding period for a property investment, this disposal enabled the Company to crystalise significant value from these assets, resulting in an annualised ungeared IRR in excess of 7% over the period of ownership (including both acquisition and sales costs) and is a testament to the Group's asset management expertise.

Scott Steven, Head of Asset Management at Target Fund Managers, commented:

"These care homes have been a successful investment for the Group, delivering a consistent and attractive rental yield over the period of ownership, combined with the realisation of a capital uplift on disposal. We care deeply about the quality of our assets and the services they facilitate; however we are not unduly attached to holding onto the bricks and mortar where we identify opportunities to improve both the overall portfolio and the Group's capital structure. This disposal is a clear illustration of our ability to pro-actively manage the portfolio to provide an attractive and sustainable level of income, together with the potential for growth, from our diversified portfolio of modern, purpose-built care homes."

LEI: 213800RXPY9WULUSBC04

 

All enquiries:

Target Fund Managers Limited

Kenneth MacKenzie / Gordon Bland

 

01786 845 912

Stifel Nicolaus Europe Limited

Mark Young / Rajpal Padam / Catriona Neville

 

020 7710 7600

FTI Consulting

Dido Laurimore / Richard Gotla / Talia Shirion

020 3727 1000

TargetHealthcare@fticonsulting.com

 

Notes to editors:

UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes.

The Group's portfolio at 31 March 2024 comprised 98 assets let to 33 tenants with a total value of £934.8 million.

The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.

 

Important information

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the Market Abuse Regulations (EU) No. 596/2014, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSEMFAMELSEFM
NO INVESTMENT ADVICE

This content is published by Proactive Investors Limited and made available subject to the terms and conditions of use of its website (see Terms of Use).

Proactive Investors is a full-service financial newswire. We produce independent, objective financial journalism and do not provide personalised investment advice, act as a broker, or recommend specific securities to individual investors.

Financial content published on this Site is produced under the journalist exemption provided for in Article 20 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, and in accordance with FCA guidance at PERG 8.12. Where a communication is not otherwise exempt, it is issued or approved for distribution in the UK by Proactive Investors Limited.

All information used in the preparation of this communication has been compiled from publicly available sources that we believe to be reliable, however, we cannot, and do not, guarantee the accuracy or completeness of this communication.

This communication is intended for information purposes only and does not constitute investment advice, a personal recommendation, an offer, solicitation, or inducement to buy or sell any investment or financial product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

This communication has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Before entering into any transaction, investors should consider suitability for their individual circumstances and should read the relevant prospectus, term sheet, subscription agreement, information memorandum, prospectus or other offering document in full.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise, and you may not recover the amount you invest.

This communication may contain information obtained from third parties, including credit ratings and financial data. Reproduction and distribution of third-party content in any form is prohibited except with the prior written consent of the relevant third party. Credit ratings are statements of opinion and should not be relied upon as investment advice.

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read